| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8349782 | Pharmacological Reports | 2018 | 13 Pages |
Abstract
These findings indicate that GLP-1 receptor agonists modulate the expression of MMPs through inhibition of AKT-Thr308 phosphorylation in hCASMC. These results suggest a possible role of incretin analogue drugs in therapy of coronary atherosclerosis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Enrique Gallego-Colon, Agnieszka Klych-Ratuszny, Agnieszka Kosowska, Wojciech Garczorz, Mohammad Reza F. Aghdam, Michal Wozniak, Tomasz Francuz,